New research reveals a deadly fungal pathogen's vulnerabilities
The study from the Stowers Institute and the University of Georgia uncovers more than 300 potential targets for drug development for a lethal fungus.
KANSAS CITY, Mo., June 10, 2025 /PRNewswire/ -- Fungal infections, particularly in immunocompromised individuals, are responsible for nearly four million deaths annually—however, current treatments are limited and are frequently ineffective. Now, scientists at the Stowers Institute for Medical Research and the University of Georgia discover how the lethal pathogenic fungus, Cryptococcus neoformans, thrives, allowing them to identify potential novel therapeutic targets for treatment.
Published in PLoS BIOLOGY on June 5, 2025, the study refined a genetic tool to identify which genes in C. neoformans are essential for its survival. Importantly, the research team uncovered more than 1,400 required genes, including more than 300 that share no similarity with human genes, making them promising targets for new antifungal drugs with reduced risks for side effects.
"Cryptococcus neoformans kills around 150,000 people a year. It's the AIDS-defining illness in the majority of HIV patients. Current treatments are limited, and outcomes are often poor," said lead author Blake Billmyre, Ph.D., Assistant Professor at the University of Georgia and former postdoctoral researcher in the lab of Stowers Associate Investigator SaraH Zanders, Ph.D. "There is an urgent need to develop new therapies, and this study provides an atlas."
Although humans and fungi bear little resemblance, genetically, we are surprisingly similar, which has historically made antifungal drug development difficult. Identifying essential genes in fungal pathogens that have no analog to human genes is critical for pinpointing potential antifungal agents that do not harm human cells.
The team uncovered 302 ideal therapeutic targets in C. neoformans—however, because drug development is costly, the researchers also identified a subset of around 30 essential genes conserved across many pathogenic fungi, or 30 potential therapies that could destroy most fungal invaders.
"A big question in biology is which genes are essential for life as well as how they might change over evolutionary time," said Zanders. "Blake's TN-seq project opens the door to genome-wide screens for important traits in pathogenic fungi and will speed the pace of drug discovery."
The team used a genetic technique called transposon mutagenesis sequencing, or TN-seq, where they damaged C. neoformans' genome by bombarding millions of cells with small DNA segments called transposons.
"The analogy we use to explain TN-seq dates back to WWII," said Billmyre. "Fighter planes returning to hangars were mapped for bullet damage to devise ways to strengthen them. However, areas of planes lacking damage were not necessarily better reinforced, but rather were never mapped because they never returned, a phenomenon called survivorship bias."
Transposons landing within essential genes cause the fungal cells to die. By sequencing the DNA of the surviving cells, researchers can map which genes are vital for survival and which are not. Zanders explained: "The TN-seq approach mirrors this survivorship bias with transposon-ridden fungi. When we look genome-wide at all the places with and without damage, we can infer that if you damage a required region of the genome, the organism will die."
TN-seq has been used widely in bacteria and in more established fungal species like baker's yeast. This is the first time the approach was adapted for C. neoformans. It allowed the team to create a mutant library for C. neoformans—with millions of transposon-induced mutations including those in DNA that regulate essential genes. The researchers could then ask even more nuanced questions, such as which genes contribute not only to survival but also to resistance of antifungal drugs.
"Traditional methods involve deleting one gene at a time, but TN-seq lets us make deletions for the entire genome, allowing us to rapidly identify the repertoire of essential genes in Cryptococcus," said Billmyre. "In addition, we were also able to use the tool to test both essential and non-essential genes that confer resistance to the most common antifungal, fluconazole."
Billmyre was recently awarded the prestigious NIH New Innovator Award to examine how fungi evolve to grow at high temperatures, which is key to understanding pathogenicity.
"My lab is now trying to understand the network of genes that enable fungal pathogens to grow at human body temperature," said Billmyre. "This can inform us of what might happen in the future if increases in global temperature cause different species of fungi to acquire pathogenic properties."
Additional authors include Caroline Craig, Joshua Lyon, Claire Reichardt, Amy Kuhn, and Michael Eickbush.
This work was funded by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) (awards: DP2GM132936, R35GM151982), the National Institute of Allergy and Infectious Diseases of the NIH (award: DP2AI184725), and with institutional support from the University of Georgia and the Stowers Institute for Medical Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
About the Stowers Institute for Medical Research
Founded in 1994 through the generosity of Jim Stowers, founder of American Century Investments, and his wife, Virginia, the Stowers Institute for Medical Research is a non-profit, biomedical research organization with a focus on foundational research. Its mission is to expand our understanding of the secrets of life and improve life's quality through innovative approaches to the causes, treatment, and prevention of diseases.
The Institute consists of 20 independent research programs. Of the approximately 500 members, over 370 are scientific staff that include principal investigators, technology center directors, postdoctoral scientists, graduate students, and technical support staff. Learn more about the Institute at www.stowers.org and about its graduate program at www.stowers.org/gradschool.
Media Contact: Joe Chiodo, Head of External Communications and Media Relations 724.462.8529 press@stowers.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-research-reveals-a-deadly-fungal-pathogens-vulnerabilities-302477680.html
SOURCE Stowers Institute for Medical Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
DKSH Brunei Strengthens Healthcare Supply Chain with Warehouse Expansion
DKSH has officially launched its newly expanded distribution center in Brunei, strengthening its capabilities to support the growth and resilience of the nation's healthcare supply chain. BANDAR SERI BEGAWAN, Brunei, June 12, 2025 /PRNewswire/ -- DKSH Brunei, a leading provider of Market Expansion Services in Asia and beyond, has officially inaugurated its newly extended warehouse facility in Brunei. The expansion adds an additional 4,000 square feet of storage capacity, reinforcing DKSH Brunei's commitment to advancing the nation's healthcare logistics infrastructure. The enhanced facility is designed to improve operational efficiency, regulatory compliance, and temperature-controlled storage, ensuring the safe and timely delivery of healthcare products nationwide. Among other things, the facility now features advanced compliance systems, improved operational workflows, and enhanced quality assurance protocols. During the launch event, Sandeep Tewari, Vice President, Healthcare, Malaysia & Brunei, DKSH, shared: "This warehouse extension marks a significant step forward following our acquisition of MediPharm Sdn. Bhd. last year. This investment reaffirms our long-term commitment to Brunei by enabling us to meet growing demand, better support our clients, and remain a trusted partner across the value chain – while enhancing our capacity to deliver high-quality healthcare solutions and create meaningful impact for the market and the communities we serve, in line with our purpose of enriching people's lives." In his address, Mr. Joel Solomon, Head, Supply Chain Management, Malaysia & Brunei, DKSH, emphasized: "This warehouse extension is not just an expansion of physical space – it is a reflection of our strategic focus on resilience, agility, and long-term partnership. Our focus remains on delivering life-saving products efficiently and reliably in Brunei, and this facility is a key step in that direction." The event welcomed esteemed guests including government officials, healthcare stakeholders, and DKSH's strategic partners. Attendees toured the upgraded warehouse. With over a decade of experience in Brunei, DKSH continues to be a trusted logistics partner in the healthcare industry, delivering compliant, reliable, and efficient supply chain solutions that help ensure access to essential medical products across the nation. About DKSH For 160 years, DKSH has been delivering growth for companies in Asia and beyond its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people's lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,940 specialists, the Business Unit generated net sales of CHF 5.7 billion in 2024. View original content to download multimedia: SOURCE DKSH Malaysia Sdn. Bhd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
Trump Admin Brings Back Hundreds of CDC Staffers it Previously Fired
The Trump administration is reversing its decision to fire hundreds of staffers from the Centers for Disease Control and Prevention (CDC) in a humiliating about-turn. A spokesperson for the Department of Health and Human Services (HHS) told STAT that the CDC will be bringing back more than 450 employees that were fired in an attempt to reorganize the agency. Some of the departments that will be reinstating employees are: The National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; the Global Health Center; the National Center for Environmental Health; the Immediate Office of the Director. These divisions helped track and prevent HIV, prevent lead poisoning in children, as well as ensure that cruise lines were safe from disease. HHS, which also oversees the CDC, first announced this 'dramatic restructuring' in March, saying that they would downsize from 82,000 to 62,000 full-time employees, claiming that it would 'save taxpayers $1.8 billion per year.' The department also revealed that it would be creating a new division called the Administration for a Healthy America (AHA), which would be led by HHS Secretary Robert F. Kennedy Jr. 'We aren't just reducing bureaucratic sprawl. We are realigning the organization with its core mission and our new priorities in reversing the chronic disease epidemic,' Kennedy said. 'This Department will do more—a lot more—at a lower cost to the taxpayer,' he claimed. He reaffirmed this sentiment in an X post in March, noting that these cuts would help eliminate the current 'alphabet soup of departments.' 'We are streamlining HHS to make our agency more efficient and more effective. We will eliminate an entire alphabet soup of departments,' he said. As a result, around 10,000 employees were fired under the guidance of Elon Musk's Department of Government Efficiency (DOGE). Yet Kennedy has already backtracked on these sweeping federal layoffs, admitting in April that too many cuts were made in the effort to 'Make America Healthy Again,' though he said that 'was always the plan.' 'We're streamlining the agencies. We're going to make it work for public health, make it work for the American people. In the course of that, there were a number of instances where studies that should have not have been cut were cut, and we've reinstated them,' Kennedy said. 'Personnel that should not have been cut were cut—we're reinstating them, and that was always the plan,' he stated.
Yahoo
6 hours ago
- Yahoo
Researchers issue urgent warning over spread of dangerous disease carried by snails: 'Leading to outbreaks in new locations'
Harmful parasites carried by snails may be spreading, in part due to human-caused climate change, according to reporting from The Telegraph in May. Marginalized populations, including women and girls, may suffer disproportionately from increased prevalence. Schistosomiasis is a parasitic infection caused by snail-carried worms. Infection typically starts with making contact with the worms in freshwater, such as in a canal, river, or pond. Person-to-person transmission can continue when urine or feces containing the parasite's eggs contaminates a water source. Symptoms — including fever, chills, coughing, and aches — can manifest within a couple of months, per the Centers for Disease Control and Prevention. Chronic infections can lead to anemia, bloody stools, urinary problems, organ damage, and more. Historically, 90% of the schistosomiasis cases requiring treatment have been located in Africa, but infections have also been documented in Asia, the Americas, and the Middle East. While the London-based outlet has reported more recent spreading in parts of Europe may be largely tourism- and migration-driven, researcher Bonnie Webster also told the publication that transmissions may emerge in further locations due to shifting weather patterns. Rising global temperatures are driving more frequent and more intense flooding events, causing snails to appear in new wet settings and increasing water contamination. "Climate change will likely cause dramatic changes in transmission which need to be understood," Webster, who studies the disease at London's Natural History Museum, told The Telegraph. "Some areas will become drier and other areas will become flooded, creating new water bodies. This will lead to snails changing where they can be found and cause the prevalence of schistosomiasis to increase and spread, leading to outbreaks in new locations." Communities in low- and middle-income countries lacking sufficient sanitation infrastructure are already disproportionately impacted by this serious issue, and women and girls are additionally vulnerable to its effects. All people can become infected by these parasites, but one manifestation of the disease — female genital schistosomiasis, or FGS — can cause sexual, reproductive, and other health concerns for women and girls. Gendered labor dynamics can make this group additionally susceptible to infection through activities like washing laundry in contaminated water. Unlimit Health says that around 56 million women and girls in sub-Saharan Africa are infected with FGS, which can go undiagnosed and, especially when misdiagnosed as a sexually transmitted infection or otherwise left untreated, can lead to bleeding, pelvic pain, ulcers, miscarriage, and infertility. It may also contribute to increased risks of HIV and cervical cancer. Overall, schistosomiasis impacts hundreds of millions of people each year, resulting in up to 20,000 deaths annually, according to The Telegraph. Unfortunately, as Webster said, "Once one snail is infected, they can infect a whole population of humans." Do you worry about getting diseases from bug bites? Absolutely Only when I'm camping or hiking Not really Never Click your choice to see results and speak your mind. While treatments exist, potential drug resistance and current medical shortages could hamper attempts to curtail infections. Experts relayed to The Telegraph that recent substantial cuts to the United States Agency for International Development may also stymie research and response efforts for neglected tropical diseases like schistosomiasis. NTDs disproportionately impact marginalized populations. The World Health Organization says they affect over 1 billion people globally and that NTDs are "often related to environmental conditions." Of course, because of travel and climate change, many such infections may spread to more communities and farther regions. The CDC notes that prevention includes clean-up of contaminated areas, implementation of sanitation systems, and avoiding swimming, wading, and washing in unsafe water. A number of these measures require funding. Staying updated about how human-caused climate change can impact health and well-being everywhere can be key to organizing effective responses to rising global temperatures. Especially together in groups, friends and neighbors can make a difference by exploring these issues, raising awareness, supporting pro-environment policies, and taking on climate-conscious shifts at home to help address the extreme weather that imperils billions worldwide. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
